FEMALE LETTER OF NECESSITY FOR
BIOIDENTICAL HORMONE REPLACEMENT THERAPY (BHRT)
To Whom It May Concern,
Bioidentical hormone replacement therapy (BHRT) utilizes plant-derived hormones that are structurally identical to those naturally produced by the human body. These hormones are formulated in specialized 503B compounding pharmacies to ensure precision and consistency in their composition. BHRT can be administered through various forms, including pellets, creams, gels, injections, patches, and troches.
Pellet therapy, in particular, offers a unique advantage by providing a steady and sustained release of hormones directly into the bloodstream. Unlike other delivery methods, which can lead to fluctuating hormone levels, pellet therapy maintains consistent levels over several months, minimizing the "roller coaster" effect commonly experienced with injections, gels, or patches. This method supports optimal symptom management and long-term hormonal balance.
Each patient’s hormone therapy regimen is personalized based on a comprehensive evaluation of medical history, symptoms, laboratory results, and response to prior treatments. The individualized dosing ensures that the therapy aligns with the patient's specific needs, optimizing effectiveness while minimizing side effects.
Bioidentical hormone therapy has been shown to alleviate symptoms associated with hormone imbalances, including but not limited to fatigue, mood disturbances, cognitive decline, weight gain, decreased libido, hot flashes, night sweats, and overall diminished quality of life. By addressing these imbalances, BHRT enhances both physical and mental well-being, supporting improved daily functioning.
We kindly request reimbursement consideration for this medically necessary treatment under the following ICD-10 codes, which are commonly associated with hormone deficiencies and related conditions:
E28.2 – Polycystic ovarian syndrome (PCOS)
E28.39 – Other ovarian failure
E28.8 – Other ovarian dysfunction
E34.9 – Endocrine disorder, unspecified
N95.1 – Menopausal and female climacteric states
N95.8 – Other specified menopausal and perimenopausal disorders
N95.9 – Unspecified menopausal and perimenopausal disorder
R68.89 – Other general symptoms (used for fatigue, brain fog, etc.)
Z79.890 – Hormone replacement therapy for age-related and medical conditions
Thank you for your attention to this matter. Please feel free to reach out for any additional information regarding this request.
Sincerely,
Mia Hartman, FNP